|

A Study of Tris-Hydroxymethyl Aminomethane (THAM) Versus Sodium Bicarbonate in Cardiac Surgical Patients

RECRUITINGPhase 4Sponsored by Mayo Clinic
Actively Recruiting
PhasePhase 4
SponsorMayo Clinic
Started2026-09-14
Est. completion2027-12
Eligibility
Age21 Years+
Healthy vol.Accepted
Locations1 site

Summary

The purpose of this research is to determine if two commonly used medications to treat metabolic acidosis in the setting of cardiac surgery, sodium bicarbonate and THAM, are equivalent.

Eligibility

Age: 21 Years+Healthy volunteers accepted
* Inclusion criteria

  * Cardiothoracic surgery with use of cardiopulmonary bypass
  * Presence of metabolic acidosis (defined as a base excess of \<-5)
  * Minnesota Research Authorization
* Exclusion criteria

  * Non-cardiac surgery patients or cardiac surgery without cardiopulmonary bypass
  * Absence of metabolic acidosis (metabolic acidosis being defined as a base excess of \<-5)
  * Pregnant patients
  * Prisoners
  * Opt out of Minnesota Research Authorization

Conditions2

Heart DiseaseMetabolic Acidosis

Interventions2

Locations1 site

Mayo Clinic
Rochester, Minnesota, 55901
Nicole M. Lenort, RRT, LRT866-265-9263

Find trials near these locations

Related trials

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.